Vivek Gautam Portfolio

Hi

@Vivek_6954

I came across below news

Aurobindo Pharma to raise $250-300 mn through QIP, equity dilution of 3-5%
As per the media flash, Aurobindo is likely to launch QIP Issue and is looking to raise $250-300 mn (Rs1650-1950 crore).
The promoter’s stake in company is likely to remain above 50%. Total equity dilution to be around 3-5%.

Would like to know your views on the same. (Wont the market take this negatively)

I have entered about a month ago in Aurobindo (seeing thier pipeline of Drug Approvals)
although right now very small position.

Regards,
Kapil Gupta